APOE and Alzheimer disease: A top key regulator of female AD gene networks was determined to be lipoprotein receptor-related protein 10 (LRP10), potentially driving sex differences based on its high regulatory strength and network connectivity, sex-specific differential expression, and dependence on APOE4 gene dosage [72].